Healthcare Global Enterprises Ltd
NSE:HCG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Healthcare Global Enterprises Ltd
Income from Continuing Operations
Healthcare Global Enterprises Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Healthcare Global Enterprises Ltd
NSE:HCG
|
Income from Continuing Operations
₹255.1m
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
Income from Continuing Operations
₹14.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
28%
|
CAGR 10-Years
16%
|
|
|
F
|
Fortis Healthcare Ltd
NSE:FORTIS
|
Income from Continuing Operations
₹9.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
22%
|
|
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
Income from Continuing Operations
₹14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Narayana Hrudayalaya Ltd
NSE:NH
|
Income from Continuing Operations
₹7.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Global Health Ltd
NSE:MEDANTA
|
Income from Continuing Operations
₹4.8B
|
CAGR 3-Years
35%
|
CAGR 5-Years
68%
|
CAGR 10-Years
N/A
|
|
Healthcare Global Enterprises Ltd
Glance View
HealthCare Global Enterprises Ltd. provides imaging and diagnostics services for cancer treatment. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-03-30. The firm is involved retail sale of pharmaceuticals, medical and orthopedic goods and toilet articles. The company operates cancer care network under the HCG brand. The company operates infertility treatment clinics providing assisted reproductive services under brand Milann. The firm operates eight Milann fertility centers, which provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. Milann fertility centers also offer training programs for fertility specialists and embryologists. Under the Triesta brand, it provides clinical reference laboratory services with specialization in oncology.
See Also
What is Healthcare Global Enterprises Ltd's Income from Continuing Operations?
Income from Continuing Operations
255.1m
INR
Based on the financial report for Dec 31, 2025, Healthcare Global Enterprises Ltd's Income from Continuing Operations amounts to 255.1m INR.
What is Healthcare Global Enterprises Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
21%
Over the last year, the Income from Continuing Operations growth was -61%. The average annual Income from Continuing Operations growth rates for Healthcare Global Enterprises Ltd have been 21% over the past three years .
